A Comparison of Bacterial Growth Inhibiting Effects of Six Commercially Available Mouthrinses

Abstract

In this study the bacterial growth inhibiting effects of six commercially available mouthrinses (Hibident®, Prodent®, Merocet®, Listerine®, Veadent® and Meridol®) were determined. Hibident® was used as a positive control. Five strains were tested (Streptococcus mutans C67, Streptococcus sanguis CH3, Veillonella alcalescens V1, Lactobacillus acidophilus JP and Actinomyces viscosus C74), as representatives of the supragingival human microflora. The Maximal Inhibiting Dilution (MID) was measured in batch cultures for each product and strain. With respect to the positive control, Hibident® (containing 0.2 per cent chlorhexidine), the most effective product was Meridol® (containing 125 ppm aminefluoride 297 and 125 ppm stannous fluoride) followed by Merocet® (containing 0.05 per cent cetylpyridinium chloride), Veadent® (containing 0.03 per cent sanguinarine), Listerine® (containing phenolic compounds) and Prodent® (containing 0.5 per cent sodium fluoride). Although all products have been separately reported to yield a plaque reduction in vivo, this study provides a firm basis for a comparison between products, as they were all evaluated in a similar way.